News18Lean R·
Ozempic Under Scanner: FDA Flags Rare Eye-Stroke Risk, Raises Vision Loss Concerns | BRASS TACKS
A major safety alert has put popular weight-loss and diabetes medicines under the scanner. The US Food and Drug Administration (FDA) has directed manufacturers of GLP-1 receptor agonist medicines to update their product labels with a warning about a potential increased risk of a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION). Often described as an “eye stroke”, NAION occurs when blood flow to the optic nerve is reduced. It can cause sudden, painless vision lo…
Read at News18 →
